ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its work spans treatment and response assessment across several cancers. It includes an early study of a docetaxel-based drug designed to target integrins, and bone scans in breast cancer that has spread to bone.
| Organization | ESMO 2026 Attendance |
|---|---|
DA Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Türkiye | |
Oncology training and research hospital in Ankara, Türkiye. | Poster Fri Oct 23 13:00–15:00 First-in-human phase Ia/Ib study of RS-0139, an integrin-targeted docetaxel prodrug, in advanced solid tumors Gastrointestinal cancersGynaecological cancersLung & thoracic cancersSarcoma, CNS, head & neck and rare cancersGenitourinary cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Treatment response and clinical outcomes of tyrosine kinase inhibitors in metastatic differentiated thyroid cancers Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 15:15–16:00 |
Find decision makers at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Tell us what you sell and we’ll find the people at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction